GB1593389A - Fermentation process - Google Patents
Fermentation process Download PDFInfo
- Publication number
- GB1593389A GB1593389A GB1310/77A GB131077A GB1593389A GB 1593389 A GB1593389 A GB 1593389A GB 1310/77 A GB1310/77 A GB 1310/77A GB 131077 A GB131077 A GB 131077A GB 1593389 A GB1593389 A GB 1593389A
- Authority
- GB
- United Kingdom
- Prior art keywords
- species
- penicillium
- carried out
- strain
- nutrient medium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/26—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D307/30—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/32—Oxygen atoms
- C07D307/33—Oxygen atoms in position 2, the oxygen atom being in its keto or unsubstituted enol form
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/04—Oxygen as only ring hetero atoms containing a five-membered hetero ring, e.g. griseofulvin, vitamin C
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Description
(54) FERMENTATION PROCESS
(71) We, IMPERIAL CHEMICAL INDUSTRIES LIMITED, Imperial
Chemical House, Millbank, London, SWlP 3JF, a British Company, do hereby declare the invention, for which we pray that a patent may be granted to us, and the method by which it is to be performed, to be particularly described in and by the following statement: This invention relates to a fermentation process and, more particularly, it relates to a fermentation process for the production of (+)-2-(5ss-n-butyl-4-ss-hydroxy-2- oxo-tetrahydrofaran-3p-yl ) 2a-methylacetic acid which possesses valuable ulcer-heating properties.
The production of dihydrocanadensolide together with up to 3% w/w canadensolide by fermentation of Penicillium canodense, and in Darticular of the strain identified as No. 95493 of the Commonwealth Mycological Institute, Kew, England, in an aqueous nutrient medium, has been described in U.K. Patent Specification
Serial No. 1434595, the amount of canadensolide being reduced by increased fermentation times. We have now discovered, and herein lies our invention, that if the nutrient medium from such a fermentation (or from fermentation of a related organism) is solvent extracted at a pH within a specific range, then quite unexpectedly the mono-lactone ( ) 2 -2 (Sp-n-butyl-4/3-hydroxy-2-oxo-tetrahydrofuran-3.R-yl ) -2ot- methylacetic acid may be obtained.
According to the invention there is provided a fermentation process for the pro ducticn of ( )-2-(3 )-2-(5ss-n-4ss-hydroxy-2-oxo-tetrahydrofuran-3ss-yl)-2-methylacetic acid having the formula:
which comprises the cultivation of a dihydrocanadensolide yielding strain of a species of the genus Penicillium or of the genus As per gillus, in an aqueous nutrient medium containing a source of assimilahle carbon and a source of assimilable nitrogen, extraction of the culture filtrate at a pH from 3.v7.0 with a substantially water immiscible organic solvent, and evaporation of the extract to dryness.
It is to be understood that the stereo-chemistry depicted in formula I is relative, and that the absolute configuration may in fact be the mirror image of that depicted.
For convenoence, the αss system of representing stereocbemistry is used throughout this specification and the numbering is based on 2-(2-oxo-tetrahydrofuran-3-yl)-acetic acid having the formula:
In this specification, a dihydrocanadensolide yielding strain of a species of the genus Penicillium or AsperRiNlts means a species of the genus Penicillium or Asper gillus which, on cultivation in an aqueous nutrient medium such as described herein, followed by extraction of the culture filtrate thereby obtained with a substantially water immiscible organic solvent, such as described herein, at a pH of less than pH 3.0, and then evaporation of the extract to dryness, yields dihydrocanadensolide.
A suitable species of the genus Penicinium is, for example, the species Penicillium candense. for example the strain identified as No. 95493 of the Commonwealth
Mycological Institute (CMI), Kew, England, or the species Penicillium arenicola, for example the strain identified as No. 555.70 of the Cetraalbureau voor Schimmelcultures (CBS), Baarn, Netherlands.
A suitable species of the genus Aspergillus is, for example, the species Aspergiltus terricota var. indicus, for example, the strain identified as CBS No. 167.63.
A particularly preferred strain of a species of the genus Penicillium, however, is that referred to above identified as CMI No. 95493.
A suitable source of assimilable carbon is, for example, glucose, sucrose or molasses, of which glucose is preferred. The source of assimilable carbon is generally present in the nutrient medium at a concentration of 2 to 12% by weight and preferably at a concentration of 8 to 10% by weight.
A suitable source of assimilable nitrogen may be conveniently provided, for example, by an ammonium salt of an inorganic acid, for example, of phosphoric, hydrochloric or sulphuric acid, by an ammonuim salt of an organic acid, for example, of tartaric or acetic acid, or by a source of organic nitrogen, for example a yeast extract. The source of assimilable nitrogen is generally present in the nutrient medium such that there is a concentration of 0.01% to 0.10% by weight of elementary nitrogen, and preferably 0.02% to 0.04% by weight, available in the medium.
In addition, the medium will also contain generally smaller quantities of essential elements, such as phosphorus (for example as potassium hydrogen phosphate or diammonium hydrogen phosphate), magnesium (for example as magnesium carbonate or sulphate), sulphur (for example as a metal sulphate) and potassium (for example as potassium carbonate or chloride), together with generally still smaller quantities of one or more so called trace-elements, such as iron, copper, zinc, manganese or molybdenum, as suitable salts.
The cultivation is conveniently carried out at a temperature in the range, for example, 18--300C, but is preferably carried out in the range 24--27"C.
The fermentation process may be carried out either using conventional surface culture conditions or using conventional aerated stirred culture conditions, which are preferred. When stirred culture conditions are used, the fermentation is preferably carried out for at least 7 days before filtration and extraction is carried out.
The fermentation process is preferably carried out with the pH of the nutrient medium controlled in the general range pH 4.e-5.8, and initially at or near pH 4.5, for example at pH 4.3--4.8. The pH may be conveniently controlled, for
example, by external means, for example by periodic addition of a strong base such as potassium hydroxide, or by internal means, for example by inclusion of a suitable
buffer, for example sodium hydrogen malate, tri-sodium citrate or sodium lactate.
Although the compound of formula I may be isolated from the culture filtrate
(obtained from the fermentation broth) by extraction at a pH in the range 3.v7.0 with a substantially water-immiscible organic solvent, a preferred pH at which to
carry out the extraction of the culture filtrate is in the range, for example, pH 3.8-5.0,
and especially in the range pH 4.0-4.5.
A suitable, substantially water-immiscible organic solvent is, for example, chloroform, ethyl acetate, or butyl acetate, and of these ethyl acetate is preferred. The evaporation of the extracts to dryness is preferably carried out as rapidly as possible, under reduced pressure, and at a temperature below 30"C.
As stated above, the compound of formula I, which is obtainable by the process
of the invention, possesses valuable ulcer healing properties. These properties may be conveniently demonstrated in a test where the compound being evaluated is dosed orally or subcutaneously daily for 21 days to rats in which duodenal ulceration has been produced by application of acetic acid to the duodenum. Ulcer healing activity is then assessed on the basis of a substantial reduction in the size or incidence of the duodenal ulcers as compared with the ulcers of an undosed control group. In this test the compound of formula I shows significant activity at a daily oral dose of 5 mg./kg., and during the period of the test no signs of overt toxicity were observed with the compound of formula I.
When used to produce an ulcer healing effect in warm blooded animals a compound of formula I is administered, preferably as a suitable pharmaceutical composition, at a daily oral or subcutaneous dose of 50 mg./kg. or less, preferably from 0.25 to 5 mg./kg., repeated if necessary at 4-5 hourly intervals. In man this is equivalent to a dose of 12.5-250 mg., four times per day.
The invention is illustrated but not limited by the following Examples in which "Oxoid", "Cerelose" and "Gas-chrom Q" are trade-marks, and yields (where given) are purely illustrative, and are not to be construed as the maximum attainable: Example 1.
An agar slant of nutrient medium (45 ml.) was prepared comprising:
Potato extract (from 200 g. of peeled and
chopped potatoes boiled in one litre of
deionised water for 20 minutes, then strained)
Glucose ("Cerelose" brand) 5.0% w/v
Agar ("Oxoid" No. 3) 20 g.
Deionised water to 1 litre and was sterilised by boiling for 20 minutes at 15 p.s.i. The slant was inoculated with
Penicillium canadense C.M.I. 95493 (previously maintained on an agar medium containing 2.0% w/v potato extract, 2.0% w/v carrot extract and 2.5% w/v "Oxoid" agar No. 3) and incubated at 25 C. for 24 days. The mycelium and spores from the slant were rubbed off into sterile water (100 ml.) and the suspension therebv obtained was added to one litre of medium containing: O( + )-tartaric acid 0.266% w/v
Diammonium tartrate 0.266% w/v
Diammonium hydrogen phosphate 0.04two w/v
Potassium carbonate (anhydrous) 0.04% w/v
Magnesium carbonate trihydrate 0.027% w/v
Ammonium sulphate 0.016% w/v
Zinc sulphate heptahydrate 0.0042% w/v
Ferrous sulphate heptahydrate 0.0042% w/v
Yeast extract ("Oxoid") 0.10% w/v
Glucose "Cerelose" brand) 5.0% w/v
Deionised water to 100.0% which had been adjusted to pH 5.6 by addition of aqueous potassium hydroxide solution and then sterilised by autoclaving at 15 p.s.i. for 30 minutes. The mixture was shaken in a 2 1. conical flask, using a rotary shaker. at 200 r.p.m. for 2 days at 25"C. Two separate portions (200 ml.) of the resulting broth were used to inoculate two separate portions (1 1.) of an inoculum medium A containing:
Glucose ("Cerelose" brand) 5.0% w/v
Diammonium tartrate 0.24% w/v
Potassium dihydrogen phosphate 0.50% w/v
Magnesium sulphate heptahydrate 0.1% w/v
Trace element concentrate 0.2% w/v
Deionised water to 100.0% w/v which had been adjusted to pH 5.6 by addition of aqueous potassium hydroxide solution and had then been sterilised by autoclaving at 15 p.s.i. for 30 minutes.
The trace element concentrate contained the following ingredients:
Ferrous sulphate heptahydrate 0.1% w/v
Cupric sulphate pentahydrate 0.015% w/v
Zinc sulphate heptahydrate 0.1% w/v
Manganese sulphate tetrahydrate 0.01% w/v
Potassium molybdate 0.01% w/v
Deionised water to 100.0%
The resulting mixture was shaken at 200 r.p.m. on a rotary shaker for 5 days at 25"C.
The contents of the flasks were added to a 40 1. glass fermentation vessel containing 33 1. of a production medium similar to the inoculum medium A described above but with the addition of a further 5.0 w/v of glucose ("Cerelose" brand)
and 0.45% w/v of sodium hydrogen malate. [The pH of the production medium
had first been adjusted to 5.6 and sterilised by autoclaving, the pH after which being 5.75].
The fermentation was carried out at a temperature of 25 0C with stirring at
410 r.p.m. and aeration at a rate of 15 1./minute. After 10 days incubation
the broth was filtered and the culture filtrate pH of 5.8 was adjusted to
4.5 by addition of hydrochloric acid. A portion (15 1.) of the filtrate was
then extracted with ethyl acetate (2 X 5 1.). The extracts were combined, dried (Na2SO4) and evaporated to dryness under reduced pressure at a temperature not
exceeding 300 C. giving a semi-solid residue (37.7 g.). The residue was triturated
with ether (100 ml.), filtered and the solid thus obtained washed with ether (2 X 20
ml.) to give (+)-2-(5 -n-butyl-4 -hydroxy-2-oxo-tetrahydrofuran-3, -yl)-2a-methyl- acetic acid (10.3 g.). This compound was further purified by dissolving in a minimum
volume of acetone at 20-250C. and adding, with stirring, 5-10 times that volume
of light petroleum (b.p. 60-80). The resulting pure crystalline precipitate was
filtered and washed with light petroleum (b.p. 60-80) to give material m.p. 114 116"C., [ < Y],D28 + 77 (c, 2.5:; methanol) of Rip45 (on silica gel 0.2 mm plates,
developed in chloroform:methanolic acetic acid 90:5:5) and having the following
characteristic NMR spectrum:
d,-acetone d6-acetone + TCAI Coupling 6 l | Coupling l l l Proton l Constant l l l Constant Signal | m | Type | No. | (Hz) 8 8 | Type (H z 5-n-butyl 9io. m 9 0.90-1.72 m 4.31 | 0.891.72 | dt 1 9 1 3 4.6 dt J1 - 3 J2 =7 J, 7 l J2 7 I d 3 1.46 d 3-C-CQH | 1.46 d 3 J 6.5 1.46 d J = 6.5 H C113 l J1 = 6.5 3f3-C-CO2lI 2*86 1 na l 2.86 | dq J2 "10 I 4t-H 4*49 dd 1 | J2 = 4.5 3 it 5 dd - .12 3 ii = 4.5 5.75 dd = 3ci-H 2.86 m 1 3.2 dd J2 - 10 Table Note:
The NMR spectral data was determined at 100 MH, using tetramethylsilane as an internal reference and the conventional abbreviations for complex interactions were used, for example: m: multiplet, d: doublet, t: triplet, q: quartet.
TCAI stands for trichioroacetyl isocyanate.
Example 2.
An agar slant of nutrient medium (45 ml.) was first prepared comprising:
Potato extract (from 200 g. of peeled and chopped
potatoes boiled in one litre of deionised water for
20 minutes, then strained)
Glucose ("Cerelose" brand! 20 g.
Agar "Oxoid" No. 38 20 g.
Deionised water to 1 litre and was sterilised by boiling for 20 minutes at 15 p.s.i. This slant was inoculated with Penicillium canadense CMI No. 95493; previously maintained on an agar medium containing 2.0% w/v potato extract, 2.0% w/v carrot extract and 2.5% w/v "Oxoid" agar No. 3) and then incubated at 25 0C. for 20 days. The mycelium and spores from the slant were rubbed off into sterile water (100 ml.) and the suspension thereby obtained was added to one litre of an inoculum medium having the same composition as the inoculum medium A in Example 1, and which had been previously adjusted to pH 5.6 by addition of aqueous potassium hydroxide solution and then sterilised by autoclaving at 15 p.s.i. for 30 minutes. The mixture obtained was then shaken at 200 r.p.m. on a rotary shaker for 7 days at 250C.
Two such portions of the inoculum mixture thereby obtained were added to a 40 1. glass fermentation vessel containing 33 1. of a production medium similar to the inoculum medium A described in Example 1, but containing an additional 5.0% w/v of glucose ("Cerelose" brand) and 0.45% w/v of sodium hydrogen malate.
[The pH of the production medium had been previously adjusted to 5.6 and then sterilised by autoclaving, the pH after which being 5.5).
The fermentation was carried out at a temperature of 25"C. with stirring at 410 r.p.m. and aeration at a rate of 15 1./minute. After 14 days incubation the broth was filtered and the culture filtrate pH of 5.3 was adjusted to 4.0 by addition of
hydrochloric acid. The filtrate (12.5 1.) was then extracted with ethyl acetate ( 2 X 6 1.). The extracts were combined, dried (Na2SO4) and evaporated to dryness under reduced pressure at a temperature not exceeding 300C. giving a semi-solid residue.
This residue was triturated with ether (60 ml), filtered and the solid thus obtained was washed with ether (2 X 20 ml.) to give (+)-2-(5 -n-butyl-4, -hydroxy-2-oxo- tetrahydrofuran-3 -yl)-2ut-methylacetic acid (10.4 g), identical with the material isolated in Example 1 as judged by IR and NMR spectroscopy and TLC comparison.
Example 3.
An inoculum of Penicillium canadense (CMI No. 95493) was prepared as described in Example 2. A portion (500 ml.) of this inoculum was added to a 14 1. glass fermentation vessel containing 12 1. of a production medium containing: Glucose "Cerelose" brand 10% w/v
Diammonium tartrate 0.24% w/v
Potassium dihydrogen orthophosphate 0.50% w/v
Magnesium sulphate heptahydrate 0.10% w/v * Trade element cencentrate 0.20% v/v
Deionised water to 100% [*Identical composition to that used in Example 1].
[The pH, of this medium had been adjusted to 5.6 by addition of aqueous potassium hydroxide solution and had then been sterilised by autoclaving at 15 p.s.i.
for 30 minutes.
The fermentation was carried out at a temperature of 250C. with stirring at 410 r.p.m., and aeration at a rate of 6 I./minute. During the first five days of the fermentation the pH was maintained at 4.3-4.6 by automatic addition of aqueous potassium hydroxide solution controlled on demand by a pH-meter. Thereafter the pH was allowed to rise so that after 14 days incubation, the pH of the broth was 5.1. The broth was then filtered to give a culture filtrate (C) (6.5 1.).
A portion (6.0 1.) of filtrate C was adjusted to pH 4.0 by addition of hydrochloric acid and then extracted with ethyl acetate (2 X 3 1.). The combined extracts were dried (Na2SO,) and evaporated to dryness under reduced pressure at a temperature at or below 30"C. The semi-solid residue obtained was triturated with ether (60 ml.).
The mixture was filtered and the solid thus obtained was washed with ether (2 X 20 ml.) to give ( + ) (+ (5 -n-butyl-4 -hydroxy-2-oxo-tetrahydrofuran-3, -yll -2,-methyl- acetic acid (6.2 g.) identical with that obtained in Example 1, as judged by IR and
NMR spectroscopy and TLC comparison.
Example 4.
A portion (500 ml) of the culture filtrate C contained in Example 3 was extracted at various pH values and the quantity of (+)-2-(5 P-n-butyl-P-hydroxy-2-oxo -tetra- hydrofuran-3, -yl)-2xr-methylacetic acid (B) obtained estimated by GLC following its conversion to the bis(trimethylsilyl)derivative, using the following procedure:- An aliquot of filtrate C (50 ml.) from 3) was adjusted to a particular pH and extracted twice with ethyl acetate (30 ml., then 15 ml., shaking for 1 minute with eaci: portion). The combined extracts were dried (Na2SO4, 10 g.) and filtered. The residue was washed with ethyl acetate (5 ml.) and the combined filtrate and washings were made up to a volume of 50 ml. with further ethyl acetate. An aliquot (50 ,sol.) of this solution was removed and mixed with analytical grade pyridine (100 yl.) and a (tri-methylsilyl) derivative of B by Gas Liquid Chromatography, A, using a glass portion (50 l) of a freshly prepared 10% v/v solution of trimethylchlorosilane in bis(trimethylsilvl)-acetamide was added. After 1 hour at 20-250C. this mixture was assayed for the bis(tri-methylsilyl) derivative of B by Gas Liquid Chromatgraphy, A, using a glass column (1.5 m. X 4mm.) containing silicone gum rubber, type E 301 (available from Phase Separations Ltd., Queensferry, Flintshire, U.K.) coated onto the particulate diatomaceous support known as "Gas-chrom" Q (80-100 mesh) available from Field Instruments Ltd., Orchard Road, Richmond, Surrey, U.K.), at a temperature of 245 C. and a nitrogen flow rate of 60 ml/minute employing a flame ionisation detector in a Pye Unicam Series 104 Gas Chromatograph (available from
Pye Unican Ltd., Cambridge, U.K.). Under these conditions, the bis(trimethylsilyl) derivative of B has a retention of 2.00 minutes.
Using the above procedure, the following quantities of B were shown to have been extracted from the culture filtrate C at particular pH values:-
pH mg. of Litre of C 7.0 18 6.5 89 6.0 122 5.5 316 5.0 684 4.5 663 4.0 1275 3.5 1357 3.0 1263 Example 5.
An agar slant of nutrient medium (prepared as in Example 1) was inoculated with Penicillium arenicola (CBS No. 555.70) and incubated at 250 C. for 12 days.
The mycelium and spores from the slant were rubbed off into sterile water (100 ml.).
A portion (5 ml.) of this suspension was added to a 500 ml. conical flask containing 100 ml. of the production medium described in Example 1. The flask was incubated at 25 C. on a rotary shaker.
After 14 days, the broth was filtered and the culture filtrate was adjusted to pH 4.0 by addition of hydrochloric acid. The filtrate was then extracted with ethyl acetate (2 X 20 ml.). The extracts were dried and evaporated as described in
Example 1, 2 and 3 to give solid material which yield (+ ,)-2-(5 -n-butyl-4 - hydroxy - 2 - oxo - tetrahydrofuran - 38 - yl) - 2a - methylacetic acid identical with that obtained in Example 1, as judged by IR and NMR spectrography and TLC comparison.
WHAT WE CLAIM IS:
1. A fermentation process for the production of (+)-2-(5,R-n-butyl-4 -hydroxy- 2-oxo-tetrahydrofuran-3 -yl)-2or-methylacetic acid having the formula:
which comprises the cultivation of a dihydrocanadensolide yielding strain of a species of the genus Penicillium or of the genus Aspergillus, in an aqueous nutrient medium containing a source of assimilable carbon and a source of assimilable nitrogen, extraction of the culture filtrate at a pH from 3.0-7.0 with a substantially water immiscible organic solvent, and evaporation of the extract to dryness.
2. A process as claimed in claim 1 wherein the species of the genus Penicillium is the species Penicillium canadense or arenicola and the species of the genus Asper gilts is the species As per gillus terricoja var. indicus.
3. A process as claimed in claim 2 wherein the strain of the species Penicillium canadense is that identified as CMI No. 95493, the strain of the species Penicillium arenicola is that identified as CBS No. 555.70, and the strain of the species Aspergillus terricola var. indicus is that identified as CBS No. 167.63.
4. A process as claimed in claim 1 wherein the species of the genus Penicillium is the species Penicillium canadense and the species of the genus Aspergillus is the species Aspergillus terricola var. indicus.
5. A process as claimed in claim 4 wherein the strain of the species Penicillium canadense is that identified as CMI No. 95493, and the strain of the species Aspergillus terricola var. indicus is that identified as CBS No. 167.63.
6. A process as claimed in claim 1 which comprises the cultivation of the strain of the species Penicillium canadense identified as CMI No. 95493.
7. A process as claimed in any one of claims 1-6 wherein the extraction is carried out at a pH in the range pH 3.8-5.0.
8. A process as claimed in any one of claims 1-6 wherein the extraction is carried out at a pH in the range 4.0-4.5.
9. A process as claimed in any preceding claim wherein the solvent is chloroform, ethyl acetate or butyl acetate.
10. A process as claimed in any preceding claim wherein the pH of the nutrient medium is controlled at a pH in the general range pH 4.0--5.8.
11. A process as claimed in any one of claims 4-6 wherein the pH of the nutrient medium is controlled at a pH, in the range pH 4.0--5.0 12. A process as claimed in any one of claims 1-10 wherein the pH of the nutrient medium is initially controlled at pH 4.3-4.8.
13. A process as claimed in any one of claims 10-12 wherein the pH of the nutrient medium is controlled by etxernal means by periodic addition of a strong base.
14. A process as claimed in claim 13 wherein the strong base is potassium hydroxide.
15. A process as claimed in one of claims 1012 wherein the pH of the nutrient medium is controlled by internal means by inclusion therein of a suitable buffer.
16. A process as claimed in claim 15 wherein the buffer is sodium hydrogen malate, tri-sodium citrate or sodium lactate.
17. A process as claimed in any preceding claim wherein the cultivation is carried out using conventional aerated stirred culture conditions.
**WARNING** end of DESC field may overlap start of CLMS **.
Claims (30)
1. A fermentation process for the production of (+)-2-(5,R-n-butyl-4ss-hydroxy- 2-oxo-tetrahydrofuran-3ss-yl)-2or-methylacetic acid having the formula:
which comprises the cultivation of a dihydrocanadensolide yielding strain of a species of the genus Penicillium or of the genus Aspergillus, in an aqueous nutrient medium containing a source of assimilable carbon and a source of assimilable nitrogen, extraction of the culture filtrate at a pH from 3.0-7.0 with a substantially water immiscible organic solvent, and evaporation of the extract to dryness.
2. A process as claimed in claim 1 wherein the species of the genus Penicillium is the species Penicillium canadense or arenicola and the species of the genus Asper gilts is the species As per gillus terricoja var. indicus.
3. A process as claimed in claim 2 wherein the strain of the species Penicillium canadense is that identified as CMI No. 95493, the strain of the species Penicillium arenicola is that identified as CBS No. 555.70, and the strain of the species Aspergillus terricola var. indicus is that identified as CBS No. 167.63.
4. A process as claimed in claim 1 wherein the species of the genus Penicillium is the species Penicillium canadense and the species of the genus Aspergillus is the species Aspergillus terricola var. indicus.
5. A process as claimed in claim 4 wherein the strain of the species Penicillium canadense is that identified as CMI No. 95493, and the strain of the species Aspergillus terricola var. indicus is that identified as CBS No. 167.63.
6. A process as claimed in claim 1 which comprises the cultivation of the strain of the species Penicillium canadense identified as CMI No. 95493.
7. A process as claimed in any one of claims 1-6 wherein the extraction is carried out at a pH in the range pH 3.8-5.0.
8. A process as claimed in any one of claims 1-6 wherein the extraction is carried out at a pH in the range 4.0-4.5.
9. A process as claimed in any preceding claim wherein the solvent is chloroform, ethyl acetate or butyl acetate.
10. A process as claimed in any preceding claim wherein the pH of the nutrient medium is controlled at a pH in the general range pH 4.0--5.8.
11. A process as claimed in any one of claims 4-6 wherein the pH of the nutrient medium is controlled at a pH, in the range pH 4.0--5.0
12. A process as claimed in any one of claims 1-10 wherein the pH of the nutrient medium is initially controlled at pH 4.3-4.8.
13. A process as claimed in any one of claims 10-12 wherein the pH of the nutrient medium is controlled by etxernal means by periodic addition of a strong base.
14. A process as claimed in claim 13 wherein the strong base is potassium hydroxide.
15. A process as claimed in one of claims 1012 wherein the pH of the nutrient medium is controlled by internal means by inclusion therein of a suitable buffer.
16. A process as claimed in claim 15 wherein the buffer is sodium hydrogen malate, tri-sodium citrate or sodium lactate.
17. A process as claimed in any preceding claim wherein the cultivation is carried out using conventional aerated stirred culture conditions.
18. A process as claimed in claim 17 wherein the cultivation is carried out for at
least seven days before filtration and extraction is carried out.
19. A process as claimed in any preceding claim wherein the source of assimilable carbon is glucose, sucrose or molasses.
20. A process as claimed in any preceding claim wherein the source of assimilable carbon is present in the nutrient medium at a concentration of 810% by weight.
21. A process as claimed in any preceding claim wherein the source of assimilable nitrogen is an ammonium salt of phosphoric, hydrochloric, sulphuric, tartaric or acetic acid, or a yeast extract.
22. A process as claimed in claim 21 wherein the source of assimilable nitrogen is present in the nurient medium such that there is a concentration of 0.020.04% by weight of elementary nitrogen available in the medium.
23. A process as claimed in any preceding claim wherein the cultivation is carried out at a temperature in the range 18--30"C.
24. A process as claimed in any one of claims 1-22 wherein the cultivation is carried out at a temperature in the range 24-270C.
25. A process as claimed in any preceding claim wherein the evaporation of the extract to dryness is carried out as rapidly as possible, under reduced pressure, and at a temperature below 30"C.
26. The compound of formula I as defined in claim 1 whenever prepared by a process claimed in any preceding claim.
27. A fermentation process as claimed in claim 6 substantially as described in
Example 1.
28. A fermentation process as claimed in claim 1 substantially as described in any one of Examples 1-5.
29. The compound of formula I as defined in claim 1 whenever prepared by the process of claim 27.
30. The compound of formula I as defined in claim 1 whenever prepared by the process of claim 28.
Priority Applications (19)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1310/77A GB1593389A (en) | 1977-01-13 | 1977-01-13 | Fermentation process |
| IE2580/77A IE45855B1 (en) | 1977-01-13 | 1977-12-20 | Fermentation process |
| NO774408A NO774408L (en) | 1977-01-13 | 1977-12-21 | FERMENTATION PROCESS. |
| US05/864,473 US4178213A (en) | 1977-01-13 | 1977-12-27 | Fermentation process for the production of (+)-2-(5β-n-butyl-4β-hydroxy-2-oxo-tetrahydrofuran-3β-yl)-2α-methylacetic acid |
| ZA00777664A ZA777664B (en) | 1977-01-13 | 1977-12-28 | Fermentation process |
| CA294,038A CA1108078A (en) | 1977-01-13 | 1977-12-29 | Fermentation process |
| NZ186138A NZ186138A (en) | 1977-01-13 | 1978-01-05 | Production of (+)-2-(5 -n-butyl-4 -hydroxy-2-oxotetrahydrofuran-3 -yl)-2 methyl acetic acid by fermentation |
| DK4978A DK4978A (en) | 1977-01-13 | 1978-01-05 | METHOD OF ASSEMBLY |
| BE184169A BE862718A (en) | 1977-01-13 | 1978-01-06 | FERMENTATION PROCESS |
| FI780041A FI780041A7 (en) | 1977-01-13 | 1978-01-06 | FERMENTATION PROCEDURE |
| NL7800243A NL7800243A (en) | 1977-01-13 | 1978-01-09 | FERMENTATION METHOD. |
| AU32250/78A AU3225078A (en) | 1977-01-13 | 1978-01-09 | Fermentation process |
| GR55122A GR62086B (en) | 1977-01-13 | 1978-01-09 | Fermentation process |
| FR7800816A FR2377449A1 (en) | 1977-01-13 | 1978-01-12 | FERMENTATION PROCESS FOR THE PRODUCTION OF (+) - 2- (5B-N-BUTYL-4B-HYDROXY-2-OXO-TETRAHYDROFURANNE-3B-YL) -2A-METHYLACETIC |
| SE7800363A SE7800363L (en) | 1977-01-13 | 1978-01-12 | FRESHING PROCEDURE |
| JP326578A JPS53109995A (en) | 1977-01-13 | 1978-01-13 | Fermentative production of ****22*5 betaann butyll4 betaahydroxyy22 oxootetrahydrofurann31 betaayl 1**2 beta methylacetic acid |
| IT19260/78A IT1158425B (en) | 1977-01-13 | 1978-01-13 | FERMENTATION PROCEDURE CONSISTENT IN THE CULTIVATION OF A STOCK OF A SPECIES OF THE GENUS PENICILLIUM OR OF THE ASPERGILLUS GENUS |
| DE19782801399 DE2801399A1 (en) | 1977-01-13 | 1978-01-13 | FERMENTATION PROCESS |
| ES465948A ES465948A1 (en) | 1977-01-13 | 1978-01-13 | FERMENTATION PROCEDURE FOR THE PRODUCTION OF (+) - 2- (5-BETA-N-BUTYL - 4 BETA-HYDROXY-2-OXO-TETRAHYDROFUR-RAN-3 BETA-IL) -2 ALPHA-METHYLACETIC ACID |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1310/77A GB1593389A (en) | 1977-01-13 | 1977-01-13 | Fermentation process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1593389A true GB1593389A (en) | 1981-07-15 |
Family
ID=9719775
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB1310/77A Expired GB1593389A (en) | 1977-01-13 | 1977-01-13 | Fermentation process |
Country Status (3)
| Country | Link |
|---|---|
| BE (1) | BE862718A (en) |
| GB (1) | GB1593389A (en) |
| ZA (1) | ZA777664B (en) |
-
1977
- 1977-01-13 GB GB1310/77A patent/GB1593389A/en not_active Expired
- 1977-12-28 ZA ZA00777664A patent/ZA777664B/en unknown
-
1978
- 1978-01-06 BE BE184169A patent/BE862718A/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| BE862718A (en) | 1978-07-06 |
| ZA777664B (en) | 1978-10-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE68902670T2 (en) | KS-506 CONNECTIONS AND METHOD FOR THE PRODUCTION THEREOF. | |
| US4178213A (en) | Fermentation process for the production of (+)-2-(5β-n-butyl-4β-hydroxy-2-oxo-tetrahydrofuran-3β-yl)-2α-methylacetic acid | |
| EP0087021B1 (en) | Cl 1565 antibiotic compounds and their production | |
| US4578383A (en) | CL 1565 antibiotic compounds | |
| JPH03130084A (en) | Production of trehalose | |
| DE2445581C3 (en) | Process for the preparation of D-gluconic acid-dlactam | |
| GB1593389A (en) | Fermentation process | |
| US3975235A (en) | Process for the production of cephamycin type antibiotic substances | |
| JPS5815995A (en) | Dc-4-5a1 and dc-45-a2 and their preparations | |
| US4316960A (en) | Preparation of 2,5-diketogluconic acid | |
| DE2332065C2 (en) | Process for the production of cephalosporins and their N-alkoxycarbonyl or N-arylcarbamoyl derivatives | |
| CA1039214A (en) | Antibiotic s15-1 production by streptomyces hw-64 and hw-70 | |
| EP0251327B1 (en) | Process for production of anthracycline compound r2ox2 | |
| DE69316903T2 (en) | SAINTOPINE DERIVATIVES | |
| US3564019A (en) | Tetracyclic lactone antifungal agents | |
| SU929015A3 (en) | Process for producing polysaccharide | |
| JPH054069B2 (en) | ||
| US3555075A (en) | Novel antifungal agents | |
| JPS589676B2 (en) | Nojirimycin B | |
| JPH05271267A (en) | Fr901459 substance, and its production and use | |
| EP0747486A1 (en) | Microbiological method for the synthesis of heteroaromatic caboxylic acids using microorganisms of the genus Alcaligenes | |
| SU574162A3 (en) | Method of preparing anhydro-4-carbomy1-5-oxy-1-ribofuranozylimidazole (bredinine) hydroxide | |
| US5922582A (en) | Indole alkaloid type compound 0089-D | |
| JPS5914035B2 (en) | Novel antibiotic Nanaomycin D and its production method | |
| JPS6338038B2 (en) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |